Pathophysiology and mechanisms of severe retinopathy of prematurity.
about
The role of Toll-like receptors in retinal ischemic diseasesRetinal, visual, and refractive development in retinopathy of prematurity.Promoting vascular repair in the retina: can stem/progenitor cells help?Interplay between CCN1 and Wnt5a in endothelial cells and pericytes determines the angiogenic outcome in a model of ischemic retinopathy.Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific EffectsEffect of angiotensin II type 1 receptor blocker and angiotensin converting enzyme inhibitor on the intraocular growth factors and their receptors in streptozotocin-induced diabetic rats.Genomics in the neonatal nursery: Focus on ROP.Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach.Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.Serial evaluation of retinal vascular changes in infants treated with intravitreal bevacizumab for aggressive posterior retinopathy of prematurity in zone I.Preeclampsia and Retinopathy of Prematurity in Very-Low-Birth-Weight Infants: A Population-Based StudyRetinal Pigment Epithelium Atrophy 1 (rpea1): A New Mouse Model With Retinal Detachment Caused by a Disruption of Protein Kinase C, θTreatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone.Smouldering retinopathy of prematurity: a case treated by multiple antivascular endothelial growth factor therapy.Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption.Bedside Diode Laser Photocoagulation Under Remifentanil Analgesia for Retinopathy of Prematurity: Early Structural Outcomes.Role of cytokines and treatment algorithms in retinopathy of prematurity.Inner retinal oxygen metabolism in the 50/10 oxygen-induced retinopathy model.Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathyCorrelation of interactions between NOS3 polymorphisms and oxygen therapy with retinopathy of prematurity susceptibilityRevisiting the mouse model of oxygen-induced retinopathy.The Relationship of Novel Plasma Proteins in the Early Neonatal Period With Retinopathy of Prematurity.Advances in diagnosis, clinical care, research, and treatment in retinopathy of prematurity.Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury.The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.Endothelial Progenitor Cells as Prognostic Markers of Preterm Birth-Associated Complications.Advances in understanding and management of retinopathy of prematurity.In Vivo Angiography Quantifies Oxygen-Induced Retinopathy Vascular Recovery.Abnormal retinal development in Cloche mutant zebrafishProbiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: a meta-analysis of randomized controlled trials.Agent-based computational model of retinal angiogenesis simulates microvascular network morphology as a function of pericyte coverage.Does ibuprofen treatment in patent ductus arteriosus alter oxygen free radicals in premature infants?STAT3-mediated activation of miR-21 is involved in down-regulation of TIMP3 and neovascularization in the ischemic retina.Propofol and fentanyl sedation for laser treatment of retinopathy of prematurity to avoid intubation.Mast cell hyperactivity underpins the development of oxygen-induced retinopathy.Clinical relevance of retinal structure in children with laser-treated retinopathy of prematurity versus controls - using optical coherence tomography.Abscisic acid: an antiangiogenic phytohormone that modulates the phenotypical plasticity of endothelial cells and macrophages.Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.Effect of intravitreal aflibercept on central retinal arterial blood flow in type 1 retinopathy of prematurity.
P2860
Q28072125-5EC2CDC8-59EE-489E-B6EE-C2225028AD97Q33585472-8C07B603-F51A-458C-AF99-8D0624B0945EQ33585478-820EE964-BBC1-4361-ADAE-4F9E2EDC8531Q33684492-14B3EE26-2AB6-47F2-8EF5-4CA85E8EAE69Q33845071-3DD9B2DD-F8AD-4559-BFBC-8AC6ED7A6834Q33914589-675543EC-932C-4754-A307-3927761F0F2DQ34498407-2924CBC5-1A12-4F9D-878C-14E263A1F728Q35684987-8EEF3542-00CB-419C-953E-30C08F54281BQ35776253-4CCE0E48-44CB-4D98-82B9-AE813E776E07Q35846321-EA289B9A-F7BF-4684-9D60-FD3C6FA14FD7Q35847377-37DE04C6-04E9-4E02-9BCE-594FB5DC8364Q35957541-5DBF3583-96A3-45B2-BBDD-CFB54983FB56Q36052210-DD1CAB17-A0F5-4A35-9BC7-2106BD18EC83Q36116150-6622FAF1-C943-4A47-87EC-CB2B45375865Q36197495-EE523F23-409C-4BDF-A62D-94204A75064BQ36241653-B601E9E7-0757-44B3-BC2D-198ECAD8FFCAQ36264828-DFD0D47E-E19C-4B60-8039-80F4B1DA5472Q36291702-5660FC86-44C1-4769-BE97-2BCA23D139C9Q36379513-B2A229C2-BECD-44FB-B256-AE5C8C0C4C0EQ36464950-C1D00D2F-0F0C-4B05-A303-EB4B26480DD9Q37155762-A32FB209-4D97-4887-B702-4420D118B5B9Q37316157-0C12412F-3E8C-404E-8EEC-9F8BB638510BQ37370267-763FF1D3-89DA-4901-BE7B-62F53FCF5D95Q37603245-48D0D420-E1C4-4CF0-96B1-B6A7726826B4Q38889173-71A96FD2-5EE7-4CCA-ABF2-EC0DAF3A5902Q38974217-69381C01-39E4-4F15-B0A5-9E3516F59FE4Q39052915-D54D1C36-CA95-4B16-9769-B0C196BBA9EBQ41315430-CBEFBA97-788C-4214-835D-39DA85224F9BQ42156659-E38DE990-054A-4A22-9A92-A49335CA292BQ42376142-396B2876-4C6D-483E-9275-99CF6989F371Q45065026-AEE6F2AF-C428-4CAD-BD07-D835E8392AF9Q46530400-6CE037DF-0E16-4EFF-A733-9920088848EAQ47143565-2902E43E-24D5-484A-8CC5-3B355ACECBAFQ47245728-9F9600DC-9B90-418F-887E-43D3600EE6BBQ47588675-B0587DF3-1815-4788-8C8A-7118DC43F381Q47941377-0F0ECE3F-490F-41BA-B772-D827E5BA0AB4Q48183508-A2344586-97F4-489D-B167-CDF9E3C771BEQ50853137-BBF2BD17-1DA6-41F3-BA47-69AE3CF25523Q52646207-C0923291-6266-4EC3-9F1B-6FF9F8EAFF46Q53750161-B4B96482-3753-4BD8-A2C7-F44B837A1878
P2860
Pathophysiology and mechanisms of severe retinopathy of prematurity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pathophysiology and mechanisms of severe retinopathy of prematurity.
@en
type
label
Pathophysiology and mechanisms of severe retinopathy of prematurity.
@en
prefLabel
Pathophysiology and mechanisms of severe retinopathy of prematurity.
@en
P2860
P1433
P1476
Pathophysiology and mechanisms of severe retinopathy of prematurity.
@en
P2093
M Elizabeth Hartnett
P2860
P304
P356
10.1016/J.OPHTHA.2014.07.050
P577
2014-10-14T00:00:00Z